Steve E. Krognes

Steve E. Krognes, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Guardant Health, Inc. and Denali Therapeutics Inc. We count 64 filings; the first trade dates from 19 August 2021 and the latest from 16 September 2026.

The open-market record consists of 21 sales worth €4.9M, with no purchase. The rest of the record consists of 5 share grants and 38 option exercises. So far in 2026, the count stands at no purchases and 4 sales.

Most recently, on 17 September 2026, the filings show an open-market sale worth €167k in Guardant Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.